Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and learning skills after OROS methylphenidate in adolescents with ADHD
2015-001084-39Phase 4
- Sponsor
- Janssen Pharmaceutical
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by Janssen Pharmaceutical.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on 2015-001084-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001084-39.